Five Innovative Pew-Stewart Scholars to Advance Cancer Research and Treatment
The Pew Charitable Trusts, together with the Alexander and Margaret Stewart Trust, has just announced the latest cohort of the Pew-Stewart Scholars Program, aimed at advancing cancer research. This selection marks the twelfth consecutive year of collaboration focused on supporting emerging scientists committed to making significant contributions in various areas of cancer study. The 2025 class comprises five distinguished early-career researchers, each awarded a grant that spans a total of four years to delve into crucial cancer-related topics.
As cancer affects countless individuals and families, the work of these scholars comes at a pivotal time where scientific innovation is paramount. Donna Frisby-Greenwood, the senior vice president for Philadelphia and scientific advancement at The Pew Charitable Trusts, expressed hope in the advancements that can stem from this research. She highlighted the dire need for improved diagnostic tools and treatment options, stating, "Cancer continues to have a profound impact... but scientific advancements hold hope for improving how we diagnose and treat the disease."
The new scholars hail from esteemed institutions and carry out research on diverse facets of cancer development and treatment.
Iain Clark, Ph.D. from the University of California, Berkeley, focuses on the genetic aspects of mixed phenotype acute leukemia. This leukemia variant is notably complex and aggressive, making it essential to comprehend its underlying genetic mechanisms better.
Ryan Flynn, M.D., Ph.D. from Boston Children’s Hospital aims to unravel how small molecules like RNAs and their associated proteins can influence cell behavior when it comes to diseases, opening avenues for innovative interventions in cancer therapy.
Javier Garcia-Bermudez, Ph.D. from the Children’s Medical Center Research Institute at UT Southwestern investigates how dietary fats contribute to tumor proliferation and resistance to conventional therapies. His work could shed light on potential dietary strategies as adjuncts to existing treatment modalities.
Anna Nam, M.D. from Weill Cornell Medicine explores the genetic determinants that shape both Hodgkin and non-Hodgkin lymphomas. Understanding these genetic factors may lead to better classification and more effective treatment options tailored to individual patients.
Bingfei Yu, Ph.D. from the University of Southern California is working on leveraging T cells, crucial components of the immune system, in the context of cancer immunotherapy. By dissecting how T cells identify and combat cancer cells, Dr. Yu's research could pave the way for precise immunotherapies aimed at enhancing patient outcomes.
Helen Piwnica-Worms, Ph.D., chair of the Pew-Stewart program's national advisory committee, praised the accomplishments and potential of the new scholars. She remarked, "Pew-Stewart scholars are leading transformative advances in cancer research, and these five outstanding investigators exemplify that spirit... We look forward to the impact their research will have on improving cancer treatment and patient outcomes."
With a long-standing commitment to fostering scientific advancement, The Pew Charitable Trusts strives to address complex health challenges through informed research and innovation. Established in 1948, Pew utilizes data-driven analysis to identify pressing issues and facilitate meaningful discussions. The continued partnership with the Alexander and Margaret Stewart Trust highlights the importance of supporting early-career scientists as they tackle some of the most challenging questions in cancer research.
Together, these initiatives reflect a robust commitment to discovering transformative solutions that not only enhance our understanding of cancer but may also lead to breakthroughs in treatment and care for countless patients fighting this disease.
As cancer affects countless individuals and families, the work of these scholars comes at a pivotal time where scientific innovation is paramount. Donna Frisby-Greenwood, the senior vice president for Philadelphia and scientific advancement at The Pew Charitable Trusts, expressed hope in the advancements that can stem from this research. She highlighted the dire need for improved diagnostic tools and treatment options, stating, "Cancer continues to have a profound impact... but scientific advancements hold hope for improving how we diagnose and treat the disease."
The new scholars hail from esteemed institutions and carry out research on diverse facets of cancer development and treatment.
Iain Clark, Ph.D. from the University of California, Berkeley, focuses on the genetic aspects of mixed phenotype acute leukemia. This leukemia variant is notably complex and aggressive, making it essential to comprehend its underlying genetic mechanisms better.
Ryan Flynn, M.D., Ph.D. from Boston Children’s Hospital aims to unravel how small molecules like RNAs and their associated proteins can influence cell behavior when it comes to diseases, opening avenues for innovative interventions in cancer therapy.
Javier Garcia-Bermudez, Ph.D. from the Children’s Medical Center Research Institute at UT Southwestern investigates how dietary fats contribute to tumor proliferation and resistance to conventional therapies. His work could shed light on potential dietary strategies as adjuncts to existing treatment modalities.
Anna Nam, M.D. from Weill Cornell Medicine explores the genetic determinants that shape both Hodgkin and non-Hodgkin lymphomas. Understanding these genetic factors may lead to better classification and more effective treatment options tailored to individual patients.
Bingfei Yu, Ph.D. from the University of Southern California is working on leveraging T cells, crucial components of the immune system, in the context of cancer immunotherapy. By dissecting how T cells identify and combat cancer cells, Dr. Yu's research could pave the way for precise immunotherapies aimed at enhancing patient outcomes.
Helen Piwnica-Worms, Ph.D., chair of the Pew-Stewart program's national advisory committee, praised the accomplishments and potential of the new scholars. She remarked, "Pew-Stewart scholars are leading transformative advances in cancer research, and these five outstanding investigators exemplify that spirit... We look forward to the impact their research will have on improving cancer treatment and patient outcomes."
With a long-standing commitment to fostering scientific advancement, The Pew Charitable Trusts strives to address complex health challenges through informed research and innovation. Established in 1948, Pew utilizes data-driven analysis to identify pressing issues and facilitate meaningful discussions. The continued partnership with the Alexander and Margaret Stewart Trust highlights the importance of supporting early-career scientists as they tackle some of the most challenging questions in cancer research.
Together, these initiatives reflect a robust commitment to discovering transformative solutions that not only enhance our understanding of cancer but may also lead to breakthroughs in treatment and care for countless patients fighting this disease.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.